Novel drug ensifentrine significantly controls exacerbations, improves lung function in COPD Dr. Kamal Kant Kohli10 Aug 2022 7:30 PM ISTNovel inhaled ensifentrine nebulizer therapy was associated with a significant reduction of exacerbations and improvement of lung function in COPD,...
FDA approves combination Therapy for pain due to Endometriosis Dr. Kamal Kant Kohli9 Aug 2022 7:30 PM ISTThe US Food and Drug Administration (FDA) has approved combination therapy containing relugolix, estradiol, and norethindrone acetate (Myfembree) for...
NRT, varenicline or cytisine reduce alcohol consumption also in addition to smoking cessation: JAMA Dr. Kamal Kant Kohli8 Aug 2022 9:30 AM ISTA clinical trial to test whether three proven smoking cessation treatments could also reduce alcohol intake found no differences between the...
FDA Approves First Targeted Therapy for HER2-Low Breast Cancer Dr. Kamal Kant Kohli6 Aug 2022 8:00 AM ISTThe U.S. Food and Drug Administration has approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with...
FDA approves new oral testosterone for hypogonadism Dr. Kamal Kant Kohli4 Aug 2022 11:00 AM ISTThe Food and drug administration has approved a new oral testosterone undecanoate (Kyzatrex) for men with hypogonadism. The new drug being...
Cytisine may prove a safe and effective smoking cessation therapy Dr. Kamal Kant Kohli2 Aug 2022 8:00 PM ISTResearch published in the Journal of Thoracic Oncology (JTO) shows cytisine may be a safe and effective smoking cessation therapy in lung cancer...
Few patients undergo recommended MRI screening after silicone implant breast surgery Dr. Kamal Kant Kohli2 Aug 2022 7:45 PM ISTOnly six percent of women with silicone breast implants followed the previous US Food and Drug Administration (FDA) recommendation for regular...
FDA clears PENS device for relief of post-op pain of cesarean section Dr. Kamal Kant Kohli30 July 2022 6:45 AM ISTThe US Food and Drug Administration has cleared a novel percutaneous electrical neurostimulation (PENS) device Primary Relief for symptomatic relief...
FDA approves belimumab for lupus nephritis for pediatric patients Dr. Kamal Kant Kohli28 July 2022 10:15 AM ISTThe FDA has approved belimumab for the treatment of active lupus nephritis for children who are also receiving standard therapy. The drug is being...
Rosuvastatin linked with signs of kidney damage in real world data Dr. Kamal Kant Kohli21 July 2022 1:30 PM ISTStatins can effectively lower high cholesterol, and many individuals take rosuvastatin, one member of this drug class. New research based on patient...
FDA approves Opzelura for repigmentation in nonsegmental vitiligo Dr. Kamal Kant Kohli21 July 2022 9:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved Opzelura (ruxolitinib) cream 1.5% for the topical treatment of nonsegmental vitiligo in adult...
FDA Clears novel Neurostimulation Device to treat Diabetic Neuropathic Pain Dr. Kamal Kant Kohli19 July 2022 9:45 AM ISTThe US Food and Drug Administration has cleared a percutaneous electrical neurostimulation (PENS) device for symptomatic relief of chronic,...
